| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/04/2011 | EP2316469A1 Delivery system and methods for protecting and administering dextroamphetamine |
| 05/04/2011 | EP2316468A1 Delivery system and methods for protecting and administering dextroamphetamine |
| 05/04/2011 | EP2316460A1 Solution for peritoneal dialysis |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316444A2 Use of alkanedicaroxylic acids and retinoids for the treatment of rosacea and other inflammatory skin diseases |
| 05/04/2011 | EP2316431A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol |
| 05/04/2011 | EP2316426A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 05/04/2011 | EP2316419A1 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 05/04/2011 | EP2315587A2 Therapeutic compositions containing macitentan |
| 05/04/2011 | EP1948237B1 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 05/04/2011 | EP1879572B1 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 05/04/2011 | EP1515615B1 Nutritional composition for detoxification and cancer prevention |
| 05/04/2011 | EP1494650B1 Pharmaceutical formulation comprising melatonin |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1383532B1 Combination therapy |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | EP1306429B1 Method of screening ptp zeta activity promoter or inhibitor |
| 05/04/2011 | CN102046201A Inhibitor of analgesic tolerance |
| 05/04/2011 | CN102046200A Therapeutic for hepatic cancer |
| 05/04/2011 | CN102046164A Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 05/04/2011 | CN102038955A Method for preparing anticoagulant polysulfones material by fourier reaction grafting |
| 05/04/2011 | CN102038953A Composite for local anesthesia before ophthalmologic operation and preparation method and application thereof |
| 05/04/2011 | CN102038952A Composition for improving the viability of nerve cells and use of the composition |
| 05/04/2011 | CN102038667A Materials and methods for treating viral infections with a cysteamine compound |
| 05/04/2011 | CN102038641A Preparation method of liposome medicine with outer layer modified by hydrophilic polymer |
| 05/04/2011 | CN102038633A Solid preparation of proton pump inhibitor |
| 05/04/2011 | CN102038632A Controlled release preparation for polydiacetylene lipoid anti-cancer medicaments and preparation method thereof |
| 05/04/2011 | CN101690814B Traditional Chinese medicine monomer having function of promoting growth of motoneuron |
| 05/04/2011 | CN101560521B Constructing method of VA1-missing adenovirus vector for expressing small interfering RNA (siRNA) |
| 05/03/2011 | USRE42327 Medicinal compositions improving brain function and method for improving brain function |
| 05/03/2011 | US7935718 Treatment of dyskinesia |
| 05/03/2011 | US7935710 Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | US7935682 Wound healing dressing for enhancing fibrocyte formation |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935490 Immunodiagnostic assays using reducing agents |
| 05/03/2011 | US7935351 Use of CPG oligodeoxynucleotides to induce angiogenesis |
| 05/03/2011 | US7935334 Probiotics as alternative medicines against infectious diseases |
| 05/03/2011 | CA2495886C Effervescent compositions comprising bisphosphonates and methods related thereto |
| 05/03/2011 | CA2477879C Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 05/03/2011 | CA2469649C Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 05/03/2011 | CA2438085C Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 05/03/2011 | CA2425933C Combination of catechin and quercetin for pharmaceutical or dietary use |
| 05/03/2011 | CA2390671C Methods for screening compounds active on neurons |
| 05/03/2011 | CA2378586C Replication-competent anti-cancer vectors |
| 05/03/2011 | CA2347066C Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
| 05/03/2011 | CA2341503C Probiotic, lactic acid-producing bacteria and uses thereof |
| 04/28/2011 | WO2011050325A1 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | WO2011049948A2 Neuroprotection and myelin repair using nestorone® |
| 04/28/2011 | WO2011049946A1 Combination cancer therapy with hsp90 inhibitory compounds |
| 04/28/2011 | WO2011049200A1 Antipruritic agent |
| 04/28/2011 | WO2011049036A1 Low-molecular drug-containing nanoparticle |
| 04/28/2011 | WO2011048514A1 Derivatives of n-hydroxybenzamide for treating hiv infections |
| 04/28/2011 | WO2011048479A2 Compositions that include anthocyanidins and methods of use |
| 04/28/2011 | WO2011002424A3 Solubility and stability enchancing pharmaceutical formulation comprising ezetimibe and simvastatin |
| 04/28/2011 | WO2009037584A3 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098349 Cathechins for the treatment of systemic aa amyloidosis |
| 04/28/2011 | US20110098318 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/28/2011 | US20110098303 Method of promoting nail growth using thyromimetic compounds |
| 04/28/2011 | US20110098289 Method for treating obesity |
| 04/28/2011 | US20110098266 Method of administering an injectable antibiotic to an animal |
| 04/28/2011 | US20110098260 Steroid Compounds and Formulations |
| 04/28/2011 | US20110098259 Pregnane steroids and their use in the treatment of cns disorders |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110097404 Tamper-resistant oral opioid agonist formulations |
| 04/28/2011 | CA2779233A1 Combination cancer therapy with hsp90 inhibitory compounds |
| 04/28/2011 | CA2777551A1 Neuroprotection and myelin repair using nestorone |
| 04/28/2011 | CA2777245A1 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | CA2773210A1 Derivatives of n-hydroxybenzamide for treating hiv infections |
| 04/27/2011 | EP2314716A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/27/2011 | EP2314696A1 Therapeutic uses of human Interleukin-B50 antagonist. |
| 04/27/2011 | EP2314627A2 Method for the treatment of multiple sclerosis |
| 04/27/2011 | EP2314612A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314611A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314610A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314585A1 Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 04/27/2011 | EP2314318A1 CD80 antibody for use in combination with chemotherapeutics to treat B cell malignancies |
| 04/27/2011 | EP2314301A2 Sensitization of chemotherapeutic agent-resistant neoplastic cells with various viruses |
| 04/27/2011 | EP2314299A1 Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin |
| 04/27/2011 | EP2314297A1 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer |
| 04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
| 04/27/2011 | EP2314290A1 Use of iron for treating attention deficit hyperactivity disorder in children |
| 04/27/2011 | EP2313113A1 Metered dose inhaler |
| 04/27/2011 | EP2313097A2 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 04/27/2011 | EP2313095A2 Methods and products for treating proliferative diseases |
| 04/27/2011 | EP2313084A1 An intrauterine delivery system for contraception |
| 04/27/2011 | EP1976520B1 Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy |
| 04/27/2011 | EP1827496B1 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 04/27/2011 | EP1589998B1 IL-27 and IL-2 for use in the treatment of cancer |
| 04/27/2011 | EP1554315B1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 04/27/2011 | EP1303541B1 Compositions containing metronidazole |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP1177796B1 Medicament for prevention or therapeutic treatment of liver disease |
| 04/27/2011 | CN102036685A Treatment of intervertebral disc degeneration |